ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Vicuron Pharmaceuticals (MM)

Vicuron Pharmaceuticals (MM) (MICU)

0.00
0.00
(0.00%)
終了 11月27日 6:00AM
0.00
0.00
( 0.00% )
プレマーケット: -

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
-
買値
-
売値
-
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
-
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

MICU 最新ニュース

Pfizer Completes Acquisition of Vicuron Pharmaceuticals

NEW YORK, Sept. 14 /PRNewswire-FirstCall/ -- Pfizer Inc said today that it has completed its acquisition of Vicuron Pharmaceuticals Inc. (Nasdaq: MICU; Nuovo Mercato), a biopharmaceutical...

Vicuron Pharmaceuticals - Announces Expiration of Hart-Scott-Rodino Act Waiting Period and Expected Closing Date for Acquisition

KING OF PRUSSIA, Pa., Sept. 11 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (Nasdaq: MICU; Nuovo Mercato) announces that the waiting period under the Hart-Scott-Rodino Antitrust...

Vicuron Pharmaceuticals Files New Drug Application (NDA) for Anidulafungin for Treatment of Invasive Candidiasis/Candidemia

KING OF PRUSSIA, Pa., Aug. 18 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (Nasdaq: MICU; Nuovo Mercato: MICU) announced today it filed a New Drug Application (NDA) with the U.S. Food...

Vicuron Pharmaceuticals Stockholders Approve Merger With Pfizer

KING OF PRUSSIA, Penn., Aug. 15 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals (Nasdaq: MICU; Nuovo Mercato) announced that its stockholders have voted to approve the merger agreement...

Vicuron Pharmaceuticals Announces Second Quarter 2005 Financial Results

KING OF PRUSSIA, Pa., Aug. 4 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (NASDAQ:MICUNASDAQ:NuovoNASDAQ:Mercato) today reported financial results for the second quarter ended June 30...

Pfizer to Acquire Vicuron Pharmaceuticals to Extend its Research Commitment in Anti-Infectives

Pfizer to Acquire Vicuron Pharmaceuticals to Extend its Research Commitment in Anti-Infectives Vicuron Products Anidulafungin and Dalbavancin Under Review by U.S. Food and Drug Administration NEW...

Vicuron Pharmaceuticals Receives Issued Patent for Dalbavancin Dosing by U.S. Patent and Trademark Office

Vicuron Pharmaceuticals Receives Issued Patent for Dalbavancin Dosing by U.S. Patent and Trademark Office KING OF PRUSSIA, Penn., June 2 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc...

Vicuron Pharmaceuticals Files Amendment to Anidulafungin New Drug Application (NDA) for Treatment of Esophageal Candidiasis

Vicuron Pharmaceuticals Files Amendment to Anidulafungin New Drug Application (NDA) for Treatment of Esophageal Candidiasis KING OF PRUSSIA, Pa., May 31 /PRNewswire-FirstCall/ -- Vicuron...

Vicuron Pharmaceuticals to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference and the Pacific Growth

Vicuron Pharmaceuticals to Present at the Friedman Billings Ramsey 9th Annual Growth Investor Conference and the Pacific Growth Equities Annual Life Sciences Growth Conference KING OF PRUSSIA...

Vicuron Pharmaceuticals to Present at the 2005 Needham Biotech Conference

Vicuron Pharmaceuticals to Present at the 2005 Needham Biotech Conference KING OF PRUSSIA, Pa., May 17 /PRNewswire-FirstCall/ -- Vicuron Pharmaceuticals Inc. (Nasdaq and Nuovo Mercato: MICU...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
HWHHWH International Inc
US$ 1.15
(103.54%)
5.01M
IFBDInfobird Company Ltd
US$ 2.80
(53.85%)
1.9M
CYCNCyclerion Therapeutics Inc
US$ 2.02
(48.53%)
3.38M
IDAIT Stamp Inc
US$ 0.5018
(37.48%)
8.16M
AMBAAmbarella Inc
US$ 85.81
(25.43%)
13.02k
PGHLPrimega Group Holdings Ltd
US$ 11.78
(-89.03%)
179.49k
NVXNOVONIX Ltd
US$ 2.00
(-25.65%)
187
IMGCIMG Inc
US$ 1.19
(-25.63%)
195.32k
LEGHLegacy Housing Corporation
US$ 20.00
(-22.78%)
99
ALRSAlerus Financial Corporation
US$ 17.00
(-22.66%)
200
IDAIT Stamp Inc
US$ 0.5018
(37.48%)
8.16M
HWHHWH International Inc
US$ 1.15
(103.54%)
5.01M
DUOFangDD Network Group Ltd
US$ 0.6377
(19.87%)
3.56M
CYCNCyclerion Therapeutics Inc
US$ 2.02
(48.53%)
3.38M
RGTIRigetti Computing Inc
US$ 2.47
(12.27%)
3.22M